InvestorsHub Logo
Followers 14
Posts 1735
Boards Moderated 0
Alias Born 01/21/2014

Re: Evaluate post# 21945

Saturday, 10/25/2014 10:31:31 AM

Saturday, October 25, 2014 10:31:31 AM

Post# of 722328

I suspect that any revenue from treating dogs with DCVax would be insignificant and therefor not worth bringing up as an issue, as if there was something inappropriate. Instead, it may have been able to give them some initial early insights beyond mice trials that could make the difference of this company leaping into the billion or tens of billion valuation. Any potential revenue from the dog treatment (study) would have been peanuts.


Are you kidding me??? Wow, you guys are something else. It has nothing to do with the revenue and everything to do with transparency and business ethics. If they were using a dendritic cell vaccination, who's technology do you think it may be? I would have no problem with it being used for further study, but being used to generate a profit for a private company....wrong! And before you say innuendo Doogood, ask yourself why did the treatment get pulled soon after it's origins were were questioned?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News